bluebird unveils $2.8m price for gene therapy Zynteglo on FDA approval
pharmaphorum
AUGUST 18, 2022
million price tag attached to the therapy when it was first made available in Europe, and is also well above the proposed $2.1 The company said it would give a treatment guarantee with the product, offering to reimburse health insurers up to 80% of the cost if Zynteglo stops working in the two years after it is administered.
Let's personalize your content